Skip to main content

The Biological Role of Fibrinolysis

  • Chapter
Thrombosis and Cardiovascular Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 164))

Abstract

Fibrinolysis is a basic defence mechanism of the organism designed to control the deposition of fibrin in the vascular system and elsewhere. This fibrin polymer deposition is regulated by the fibrinolytic system which acts on the insoluble protein and by splitting a limited number of peptide bonds renders it soluble.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. Collen, B. Wiman, The fast acting plasmin inhibitor of human plasma: In: Davidson, J.F., Cepelak, V., Samama, M.M., Desnoyers, P.C. Eds.: Progress in chemical fibrinolysis and thrombolysis, Vol. IV, Edinburgh: Churchill Livingstone, 1979: 11–19.

    Google Scholar 

  2. T. Astrup, Fibrinolysis: an overview: In Davidson, J.F., Rowan, R.M., Samama, M.M., Desnoyers, P.C. Eds.: Progress in chemical fibrinolysis and thrombolysis; Vol. IV, New York: Raven Press, 1978: 1–57.

    Google Scholar 

  3. K. Koie, T. Kamiya, K. Ogata, J. Takamatsu, M. Kohakura, α2 Plasmin — inhibitor deficiency Miyasato disease. Lancet 2: 1334–1336 (1978).

    Article  PubMed  CAS  Google Scholar 

  4. N. Aoki, H. Saito, T. Kamiya, K. Koie, Y. Sakata, M. Kohakura, Congenital deficiency of α2-Plasmin inhibitor associated with severe haemorrhagic tendency. J. Clin. Invest. 63:877–884. (1979).

    Article  PubMed  CAS  Google Scholar 

  5. C. Kluft, E. Vellegua, E.J.P. Brommer, Homozygous α2-antiplasmin deficiency. Lancet 2: 206 (1979).

    Article  PubMed  CAS  Google Scholar 

  6. N. Aoki, M. Moroi, Y. Sakata, N. Yoshida, M. Matsuda, Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J. Clin. Invest. 61: 1186–1195 (1979).

    Article  Google Scholar 

  7. R.C. Wohl, L. Summaria, K.C. Robbins, Physiological activation of the human fibrinolytic system. Isolation and characterisation of human plasminogen variants, Chicago I and Chicago II. J. Biol. Chem. 254: 9063–9069 (1979).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Davidson, J.F., Walker, I.D. (1984). The Biological Role of Fibrinolysis. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8616-2_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8618-6

  • Online ISBN: 978-1-4684-8616-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics